• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一千例在印度 ICU 中收治的脓毒症患者的多中心前瞻性登记研究:(SEPSIS INDIA)研究。

A multicentre prospective registry of one thousand sepsis patients admitted in Indian ICUs: (SEPSIS INDIA) study.

机构信息

Department of Critical Care Medicine, Manipal Hospital Dhakuria, P-4 & 5, CIT Scheme, LXXII, Block-A, Gariahat Road, Kolkata, 700029, India.

Medanta Institute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram, Haryana, India.

出版信息

Crit Care. 2024 Nov 19;28(1):375. doi: 10.1186/s13054-024-05176-8.

DOI:10.1186/s13054-024-05176-8
PMID:39563464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11577944/
Abstract

BACKGROUND

Sepsis is a global health problem with high morbidity and mortality. Low- and middle-income countries have a higher incidence and poorer outcome with sepsis. Large epidemiological studies in sepsis using Sepsis-3 criteria, addressing the process of care and deriving predictors of mortality are scarce in India.

METHOD

A multicentre, prospective sepsis registry was conducted using Sepsis 3 criteria of suspected or confirmed infection and SOFA score of 2 or more in 19 ICUs in India over a period of one year (August 2022-July 2023). All adult patients admitted to the Intensive Care Unit who fulfilled the Sepsis 3 criteria for sepsis and septic shock were included. Patient infected with Covid 19 were excluded. Patients demographics, severity, admission details, initial resuscitation, laboratory and microbiological data and clinical outcome were recorded. Performance improvement programs as recommended by the Surviving Sepsis guideline were noted from the participating centers. Patients were followed till discharge or death while in hospital.

RESULTS

Registry Data of 1172 patients with sepsis (including 500 patients with septic shock) were analysed. The average age of the study cohort was 65 years, and 61% were male. The average APACHE II and SOFA score was 21 and 6.7 respectively. The majority of patients had community-acquired infections, and lung infections were the most common source. Of all culture positive results, 65% were gram negative organism. Carbapenem-resistance was identified in 50% of the gram negative blood culture isolates. The predominant gram negative organisms were Klebsiella spp (25%), Escherechia coli (24%) and Acinetobacter Spp (11%). Tropical infections (Dengue, Malaria, Typhus) constituted minority (n = 32, 2.2%) of sepsis patients. The observed hospital mortality for the entire cohort (n = 1172) was 36.3%, for those without shock (n = 672) it was 25.6% and for those with shock (n = 500) it was 50.8%. The average length of ICU and hospital stay for the study cohort was 8.64 and 11.9 respectively. In multivariate analysis adequate source control, correct choice of empiric antibiotic and the use of intravenous thiamine were protective.

CONCLUSION

The general demographics of the sepsis population in the Indian Sepsis Registry is comparable to Western population. The mortality of sepsis cohort was higher (36.3%) but septic shock mortality (50.8%) was comparable to Western reports. Gram negative infection was the predominant cause of sepsis with a high incidence of carbapenem resistance. Eschericia coli, Klebsiella Spp and Acinetobacter Spp were the predominant causative organism. Tropical infection constituted a minority of sepsis population with low hospital mortality. The SOFA score on admission was a comparatively better predictor of poor outcome. Sepsis secondary to nosocomial infections had the worst outcomes, while source control, correct empirical antibiotic selection, and intravenous thiamine were protective. CTRI Registration CTRI:2022/07/044516.

摘要

背景

脓毒症是一个全球性的健康问题,发病率和死亡率都很高。中低收入国家的脓毒症发病率更高,预后更差。印度使用 Sepsis-3 标准进行的大型脓毒症流行病学研究,涉及护理过程,并得出死亡率预测因素,相对较少。

方法

在印度的 19 个 ICU 中,使用 Sepsis-3 标准(疑似或确诊感染,SOFA 评分≥2)进行了一项多中心、前瞻性脓毒症登记研究,时间为一年(2022 年 8 月至 2023 年 7 月)。纳入所有符合 Sepsis-3 标准的脓毒症和脓毒性休克成人患者。感染新冠病毒的患者被排除在外。记录患者的人口统计学、严重程度、入院细节、初始复苏、实验室和微生物学数据以及临床结局。从参与中心注意到了《拯救脓毒症运动》指南推荐的绩效改进计划。患者在住院期间或出院时进行随访。

结果

对 1172 例脓毒症患者(包括 500 例脓毒性休克患者)的登记数据进行了分析。研究队列的平均年龄为 65 岁,61%为男性。平均 APACHE II 和 SOFA 评分为 21 和 6.7。大多数患者有社区获得性感染,肺部感染是最常见的感染源。所有培养阳性结果中,65%为革兰氏阴性菌。革兰氏阴性菌血培养分离株中 50%为碳青霉烯耐药菌。主要的革兰氏阴性菌为肺炎克雷伯菌(25%)、大肠杆菌(24%)和不动杆菌(11%)。热带感染(登革热、疟疾、斑疹伤寒)在脓毒症患者中占少数(n=32,2.2%)。整个队列(n=1172)的住院死亡率为 36.3%,无休克者(n=672)为 25.6%,休克者(n=500)为 50.8%。研究队列的 ICU 和住院平均时间分别为 8.64 天和 11.9 天。多变量分析显示,充分的源头控制、正确选择经验性抗生素和使用静脉注射硫胺素具有保护作用。

结论

印度脓毒症登记研究中脓毒症患者的一般人口统计学特征与西方人群相似。脓毒症患者的死亡率较高(36.3%),但脓毒性休克死亡率(50.8%)与西方报告相当。革兰氏阴性感染是脓毒症的主要原因,碳青霉烯耐药率较高。大肠杆菌、肺炎克雷伯菌和鲍曼不动杆菌是主要的致病微生物。热带感染在脓毒症患者中占少数,住院死亡率较低。入院时的 SOFA 评分是较差预后的一个较好的预测指标。医院获得性感染引起的脓毒症预后最差,而源头控制、正确的经验性抗生素选择和静脉注射硫胺素具有保护作用。CTRI 注册号:CTRI/2022/07/044516。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f33/11577944/618724c7c74c/13054_2024_5176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f33/11577944/a5380b864b67/13054_2024_5176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f33/11577944/618724c7c74c/13054_2024_5176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f33/11577944/a5380b864b67/13054_2024_5176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f33/11577944/618724c7c74c/13054_2024_5176_Fig2_HTML.jpg

相似文献

1
A multicentre prospective registry of one thousand sepsis patients admitted in Indian ICUs: (SEPSIS INDIA) study.一千例在印度 ICU 中收治的脓毒症患者的多中心前瞻性登记研究:(SEPSIS INDIA)研究。
Crit Care. 2024 Nov 19;28(1):375. doi: 10.1186/s13054-024-05176-8.
2
Systemic Inflammatory Response Syndrome全身炎症反应综合征
3
Epidemiology and outcomes of septic shock in Japan: a nationwide retrospective cohort study from a medical claims database by the Japan Sepsis Alliance (JaSA) study group.日本感染性休克的流行病学与转归:日本脓毒症联盟(JaSA)研究组基于医疗理赔数据库的全国性回顾性队列研究
Crit Care. 2025 Jul 16;29(1):309. doi: 10.1186/s13054-025-05556-8.
4
Culture-negative sepsis may be a different entity from culture-positive sepsis: a prospective nationwide multicenter cohort study.培养阴性脓毒症可能与培养阳性脓毒症不同:一项前瞻性全国多中心队列研究。
Crit Care. 2024 Nov 25;28(1):385. doi: 10.1186/s13054-024-05151-3.
5
Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.全球肝硬化住院患者感染的流行情况和特征及临床结局:CLEARED 联盟的一项前瞻性队列研究。
Lancet Gastroenterol Hepatol. 2024 Nov;9(11):997-1009. doi: 10.1016/S2468-1253(24)00224-3. Epub 2024 Sep 5.
6
Epidemiology and Clinical Outcome of Common Multi-drug Resistant Gram-negative Bacterial Infections in a Network of Hospitals in India (IMPRES): A Multicenter Intensive Care Unit-based Prospective Clinical Study.印度医院网络中常见多重耐药革兰氏阴性菌感染的流行病学及临床结果(IMPRES):一项基于多中心重症监护病房的前瞻性临床研究
Indian J Crit Care Med. 2025 Jun;29(6):504-509. doi: 10.5005/jp-journals-10071-24988. Epub 2025 Jun 5.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
[Predictive value of norepinephrine equivalence score on the 28-day death risk in patients with sepsis: a retrospective cohort study].去甲肾上腺素等效评分对脓毒症患者28天死亡风险的预测价值:一项回顾性队列研究
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Apr;37(4):331-336. doi: 10.3760/cma.j.cn121430-20240413-00341.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.

引用本文的文献

1
The Left Ventricular Outflow Tract Velocity Time Integral as a Predictor of Fluid Responsiveness in Patients With Sepsis-Related Acute Circulatory Failure.左心室流出道速度时间积分作为脓毒症相关急性循环衰竭患者液体反应性的预测指标
Cureus. 2025 Jan 12;17(1):e77353. doi: 10.7759/cureus.77353. eCollection 2025 Jan.
2
Prognostic analysis of elderly patients with pathogenic microorganisms positive for sepsis-associated encephalopathy.脓毒症相关性脑病病原微生物阳性老年患者的预后分析
Front Microbiol. 2024 Dec 16;15:1509726. doi: 10.3389/fmicb.2024.1509726. eCollection 2024.

本文引用的文献

1
The application of artificial intelligence in the management of sepsis.人工智能在脓毒症管理中的应用。
Med Rev (2021). 2023 Nov 28;3(5):369-380. doi: 10.1515/mr-2023-0039. eCollection 2023 Oct.
2
Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction.给予硫胺素可能会增加心肌梗死重症患者的生存获益。
Front Nutr. 2023 Aug 29;10:1227974. doi: 10.3389/fnut.2023.1227974. eCollection 2023.
3
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial.
连续性与间歇性美罗培南给药在脓毒症危重症患者中的比较:MERCY 随机临床试验。
JAMA. 2023 Jul 11;330(2):141-151. doi: 10.1001/jama.2023.10598.
4
Comparison of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment Scores to predict Mortality in Sepsis.比较全身炎症反应综合征、序贯器官衰竭评估和快速序贯器官衰竭评估评分对脓毒症患者死亡率的预测价值。
J Assoc Physicians India. 2022 Aug;70(8):11-12. doi: 10.5005/japi-11001-0062.
5
Genetic variants associated with sepsis.与脓毒症相关的遗传变异。
PLoS One. 2022 Mar 11;17(3):e0265052. doi: 10.1371/journal.pone.0265052. eCollection 2022.
6
Insights Into Thiamine Supplementation in Patients With Septic Shock.脓毒症休克患者补充硫胺素的见解
Front Med (Lausanne). 2022 Jan 28;8:805199. doi: 10.3389/fmed.2021.805199. eCollection 2021.
7
Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India: A Cross-sectional Study.印度重症监护病房成年患者脓毒症患病率及转归的估计:一项横断面研究。
Chest. 2022 Jun;161(6):1543-1554. doi: 10.1016/j.chest.2021.12.673. Epub 2022 Jan 31.
8
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
9
Intensive Care in India in 2018-2019: The Second Indian Intensive Care Case Mix and Practice Patterns Study.2018 - 2019年印度的重症监护:第二项印度重症监护病例组合与实践模式研究
Indian J Crit Care Med. 2021 Oct;25(10):1093-1107. doi: 10.5005/jp-journals-10071-23965.
10
Combination therapy of thiamine, vitamin C and hydrocortisone in treating patients with sepsis and septic shock: a meta-analysis and trial sequential analysis.硫胺素、维生素C和氢化可的松联合治疗脓毒症和脓毒性休克患者:一项荟萃分析和试验序贯分析
Burns Trauma. 2021 Dec 6;9:tkab040. doi: 10.1093/burnst/tkab040. eCollection 2021.